Lu S - Search Results

1

[Research status on targeted therapy for squamous cell lung cancer].

Yuan H, Lu S. Yuan H, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2013 Oct 20;16(10):559-63. doi: 10.3779/j.issn.1009-3419.2013.10.11. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24113011 Free PMC article. Review. Chinese.

2

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Li Z, et al. Among authors: lu j, lu s. J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d. J Thorac Oncol. 2009. PMID: 19404215 Free article.

3

Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.

Zhang YF, Chen ZW, Lu S. Zhang YF, et al. Among authors: lu s. Chin Med J (Engl). 2009 Oct 20;122(20):2472-6. Chin Med J (Engl). 2009. PMID: 20079162

4

[Safety analysis of ambulatory chemotherapy in lung cancer].

Feng Y, Lu S, Song Z, Xu L, Shi Y, Chen Z. Feng Y, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):713-6. doi: 10.3779/j.issn.1009-3419.2010.07.10. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673488 Free PMC article. Chinese.

5

[Genome wide association study on lung cancer.].

Niu X, Ai X, Lu S. Niu X, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2009 Jul 20;12(7):792-8. doi: 10.3779/j.issn.1009-3419.2009.07.010. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719158 Free article. Chinese. No abstract available.

6

[Advances of maintenance chemotherapy on advanced non-small cell lung cancer.].

Ai X, Lu S. Ai X, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):14-6. doi: 10.3779/j.issn.1009-3419.2008.01.004. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20727258 Free article. Chinese. No abstract available.

7

[Perioperative chemotherapy of stage III N2 non-small cell lung cancer.].

Lu S, Yu Y. Lu S, et al. Zhongguo Fei Ai Za Zhi. 2008 Oct 20;11(5):652-6. doi: 10.3779/j.issn.1009-3419.2008.05.004. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20738906 Free article. Chinese. No abstract available.

8

Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patients.

Song Z, Yu Y, Chen Z, Lu S. Song Z, et al. Among authors: lu s. Med Oncol. 2011 Dec;28 Suppl 1:S605-12. doi: 10.1007/s12032-010-9753-3. Epub 2010 Nov 30. Med Oncol. 2011. PMID: 21116876

9

[Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Cheng BJ, Lu S, Jian H, Zhou Z, Chen ZW, Ye XY. Xu YH, et al. Among authors: lu s. Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):395-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875475 Clinical Trial. Chinese.

10

[Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].

Shen L, Li ZM, Lu S. Shen L, et al. Among authors: lu s. Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):442-6. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875485 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,118 results

Search Page

Filters